Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterNo recent work listed

Kazim M. Husain

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5067591674. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 2 papers · 2014: none · 2015: 6 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper

Papers 15

  1. Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer. Co-author DOI 10.3390/cancers14153613↗
  2. Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-4781↗
  3. Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer. First author DOI 10.1016/j.tranon.2019.11.009↗
  4. Apigenin Increases SHIP-1 Expression, Promotes Tumoricidal Macrophages and Anti-Tumor Immune Responses in Murine Pancreatic Cancer. Co-author DOI 10.3390/cancers12123631↗
  5. Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIPs. Co-author DOI 10.1186/s12935-019-0876-0↗
  6. δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis. Co-author DOI 10.18632/oncotarget.15767↗
  7. EGR-1/Bax pathway plays a role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic cancer cells. First author DOI 10.1016/j.jnutbio.2015.02.008↗
  8. Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000218↗
  9. Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-15-0104↗
  10. Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis. Co-author DOI 10.1371/journal.pone.0115546↗
  11. Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1371/journal.pone.0133562↗
  12. Triciribine Phosphate Monohydrate, an AKT Inhibitor, Enhances Gemcitabine Activity in Pancreatic Cancer Cells. Co-author PMID 26254348↗
  13. Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer. Co-author DOI 10.1158/1940-6207.capr-13-0157↗
  14. Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism. Co-author DOI 10.1371/journal.pone.0052526↗
  15. Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer. Co-author DOI 10.1158/1535-7163.mct-11-0424↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mokenge Peter Malafa · 13 shared papers, 2011–2021 · strength 0.83
  2. Saı̈d M. Sebti · 8 shared papers, 2011–2021 · strength 0.51
  3. Domenico Coppola · 5 shared papers, 2013–2020 · strength 0.38
  4. Tomar Ghansah · 3 shared papers, 2015–2022 · strength 0.30
  5. Barbara Ann Centeno · 5 shared papers, 2013–2017 · strength 0.28
  6. Krystal Villalobos-Ayala · 2 shared papers, 2020–2022 · strength 0.25
  7. Surinder K. Batra · 2 shared papers, 2019–2020 · strength 0.22
  8. Jose Gilberto Trevino · 2 shared papers, 2017–2021 · strength 0.19
  9. Rony A. Francois · 3 shared papers, 2011–2019 · strength 0.16
  10. Clayton Clopton Yates · 1 shared paper, 2022 · strength 0.14
  11. George Blanck · 1 shared paper, 2022 · strength 0.14
  12. Dung‐Tsa Chen · 3 shared papers, 2013–2015 · strength 0.14
  13. José M. Pimiento · 3 shared papers, 2013–2015 · strength 0.14
  14. Sridevi Challa · 1 shared paper, 2020 · strength 0.13
  15. Richard Kim · 1 shared paper, 2020 · strength 0.13
  16. Kun Jiang · 1 shared paper, 2020 · strength 0.11
  17. Patrick W. Underwood · 1 shared paper, 2021 · strength 0.11
  18. Aslamuzzaman Kazi · 1 shared paper, 2021 · strength 0.11
  19. Jason B. Fleming · 1 shared paper, 2021 · strength 0.11
  20. Terence Marques Williams · 1 shared paper, 2021 · strength 0.11
  21. Ashley H. Davis-Yadley · 2 shared papers, 2015 · strength 0.10
  22. Richard D. Kim · 1 shared paper, 2015 · strength 0.06
  23. Chen Wang · 1 shared paper, 2015 · strength 0.05
  24. Shari Pilon-Thomas · 1 shared paper, 2015 · strength 0.05
  25. Nadine Nelson · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.